The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,205
Dudley, R. K. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80264-3 · Cited by 5,945
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Mitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., & Mendelsohn, J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1337 · Cited by 791
de Boer, P. A. J., Crossley, R. E., & Rothfield, L. I. (1989) · Cell · doi:10.1016/0092-8674(89)90586-2 · Cited by 776
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 464
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J. M., Polikoff, J., & SATO, G. H. (1983) · PubMed · Cited by 458
RAYMOND, C. K., ROBERTS, B. S., GARRETT-ENGELE, P., LIM, L. P., & JOHNSON, J. M. (2005) · RNA · doi:10.1261/rna.2148705 · Cited by 433
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Poeck, H., Besch, R., Maihoefer, C., Renn, M., Tormo, D., Morskaya, S. S., Kirschnek, S., Gaffal, E., Landsberg, J., Hellmuth, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1887 · Cited by 387
Protein expression in E. coli minicells by recombinant plasmids
Meagher, R. B., Tait, R. C., Betlach, M., & Boyer, H. W. (1977) · Cell · doi:10.1016/0092-8674(77)90039-3 · Cited by 349
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Self-citationWu, H., Hait, W. N., & Yang, J. (2003) · PubMed · Cited by 289
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Tao, W., South, V. J., Zhang, Y., Davide, J. P., Farrell, L., Kohl, N. E., Sepp-Lorenzino, L., & Lobell, R. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.003 · Cited by 273
Bacterial Perturbation of Cytokine Networks
Wilson, M., Seymour, R., & Henderson, B. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2401-2409.1998 · Cited by 251
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Robbins, M., Judge, A., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 220
Sun, J., Blaskovich, M. A., Knowles, D. B., Qian, Y., Ohkanda, J., Bailey, R. D., Hamilton, A. D., & Sebti, S. M. (1999) · PubMed · Cited by 213
Targeting the epidermal growth factor receptor
El-Rayes, B. F., & LoRusso, P. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601921 · Cited by 184
Meade, B. R., & Dowdy, S. F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.004 · Cited by 174
Bartlett, D. W., & Davis, M. E. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21668 · Cited by 164
Villares, G. J., Zigler, M., Wang, H., Melnikova, V. O., Wu, H., Friedman, R., Leslie, M. C., Vivas-Mejia, P. E., Lopez-Berestein, G., Sood, A. K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2397 · Cited by 163
Heidel, J. D., Liu, J. Y.-C., Yen, Y., Zhou, B., Heale, B. S. E., Rossi, J. J., Bartlett, D. W., & Davis, M. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2218 · Cited by 160
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts
Sharma, A., Mayhew, E. G., Bolcsak, L. E., Cavanaugh, C., Harmon, P. A., Janoff, A. S., & Bernacki, R. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970328)71:1<103::aid-ijc17>3.0.co;2-j · Cited by 136
Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies
Pirollo, K. F., & Chang, E. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5810 · Cited by 121
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
REILLY, R. M., Kiarash, R., Sandhu, J., Lee, Y. W., Cameron, R. G., Hendler, A. L., Vallis, K. A., & Gariépy, J. (2000) · PubMed · Cited by 115
Targeting the Kinesin Eg5 to Monitor siRNA Transfection in Mammalian Cells
Barbieri-Weill, D., Garçon, L., Harper, M., Dumènil, D., Dautry, F., & Kress, M. (2002) · BioTechniques · doi:10.2144/02336st01 · Cited by 111
Targeted Delivery Systems of Small Interfering RNA by Systemic Administration
Kawakami, S., & Hashida, M. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.142 · Cited by 104
Time-and concentration-dependent penetration of doxorubicin in prostate tumors
Zheng, J., Chen, C., Au, J. L. ‐., & Wientjes, M. G. (2001) · AAPS PharmSci · doi:10.1208/ps030215 · Cited by 63
Development of an HPLC Method for Simultaneous Analysis of Five Antineoplastic Agents
Larson, R. R., Khazaeli, M. B., & Dillon, H. K. (2003) · Applied Occupational and Environmental Hygiene · doi:10.1080/10473220301432 · Cited by 52
Kaszubiak, A., Holm, P. S., & Lage, H. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.2.419 · Cited by 41
Mayer, L. D., & Shabbits, J. A. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013108524062 · Cited by 39
MacDiarmid, J. A., Madrid-Weiss, J., Amaro-Mugridge, N. B., Phillips, L., & Brahmbhatt, H. N. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4648 · Cited by 35
Self-citationBiliary excretion of irinotecan and its metabolites.
Itoh, T., Takemoto, I., Itagaki, S., Sasaki, K., Hirano, T., & Iseki, K. (2004) · PubMed · Cited by 20
Cited by
Current prospects for RNA interference-based therapies
Davidson, B. L., & McCray, P. B. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2968 · Cited by 761
van Zandwijk, N., Pavlakis, N., Kao, S. C., Linton, A., Boyer, M. J., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M. J., Bailey, D. L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30621-6 · Cited by 710
Self-citationGujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Metadata
- Authors
- MacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., Stillman, B., Graham, R. M., & Brahmbhatt, H.
- Venue
- Nature Biotechnology
- Published
- 2009-06-28
- Volume
- 27
- Issue
- 7
- Pages
- 643-651
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1983718760
- Cited by
- 272
- References
- 45
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.